Extended-release (ER) fluvastatin either alone or in combination with ezetimibe appears to effectively lower LDL-cholesterol in patients intolerant to statins

Author:  

Publisher: Adis International

ISSN: 1173-8324

Source: Inpharma, Vol.1, Iss.1605, 2007-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract